Furthermore, STAT3-deficient AML cells evade NK cells in vitro by downregulating surface ICAM-1, and lower STAT3/ICAM-1 axis activity has been linked to poorer survival in patients [194]. This evidence concerns the gene STAT3 and acute myeloid leukemia.